131 related articles for article (PubMed ID: 28043912)
1. Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts.
Luo T; Sun J; Zhu S; He J; Hao L; Xiao L; Zhu Y; Wang Q; Pan X; Wang Z; Chang S
Cancer Lett; 2017 Apr; 391():1-11. PubMed ID: 28043912
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-mediated destruction of paclitaxel and oxygen loaded lipid microbubbles for combination therapy in ovarian cancer xenografts.
Liu L; Chang S; Sun J; Zhu S; Yin M; Zhu Y; Wang Z; Xu RX
Cancer Lett; 2015 May; 361(1):147-54. PubMed ID: 25754815
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts.
Pu C; Chang S; Sun J; Zhu S; Liu H; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2014 Jan; 11(1):49-58. PubMed ID: 24237050
[TBL] [Abstract][Full Text] [Related]
4. Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo.
Liu Y; Chen S; Sun J; Zhu S; Chen C; Xie W; Zheng J; Zhu Y; Xiao L; Hao L; Wang Z; Chang S
Mol Pharm; 2019 Oct; 16(10):4104-4120. PubMed ID: 31517495
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells.
Liu H; Chang S; Sun J; Zhu S; Pu C; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2014 Jan; 11(1):40-8. PubMed ID: 24266423
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
Hu L; Hofmann J; Zaloudek C; Ferrara N; Hamilton T; Jaffe RB
Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells.
Sun J; Yin M; Zhu S; Liu L; Zhu Y; Wang Z; Xu RX; Chang S
Ultrason Sonochem; 2016 Jan; 28():319-326. PubMed ID: 26384914
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model.
Hu L; Hofmann J; Holash J; Yancopoulos GD; Sood AK; Jaffe RB
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6966-71. PubMed ID: 16203789
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.
Lu H; Li B; Kang Y; Jiang W; Huang Q; Chen Q; Li L; Xu C
Cancer Chemother Pharmacol; 2007 Feb; 59(2):175-81. PubMed ID: 16718469
[TBL] [Abstract][Full Text] [Related]
10. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts.
De Stefano I; Battaglia A; Zannoni GF; Prisco MG; Fattorossi A; Travaglia D; Baroni S; Renier D; Scambia G; Ferlini C; Gallo D
Cancer Chemother Pharmacol; 2011 Jul; 68(1):107-16. PubMed ID: 20848284
[TBL] [Abstract][Full Text] [Related]
12. Treatment of xenografted ovarian carcinoma using paclitaxel-loaded ultrasound microbubbles.
Xing W; Gang WZ; Yong Z; Yi ZY; Shan XC; Tao RH
Acad Radiol; 2008 Dec; 15(12):1574-9. PubMed ID: 19000874
[TBL] [Abstract][Full Text] [Related]
13. Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells.
Zhang Y; Chang S; Sun J; Zhu S; Pu C; Li Y; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2015 Sep; 12(9):3137-45. PubMed ID: 26212628
[TBL] [Abstract][Full Text] [Related]
14. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F
J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors.
Sui M; Chen F; Chen Z; Fan W
Int J Cancer; 2006 Aug; 119(3):712-7. PubMed ID: 16496381
[TBL] [Abstract][Full Text] [Related]
16. Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma.
Kotopoulis S; Stigen E; Popa M; Safont MM; Healey A; Kvåle S; Sontum P; Gjertsen BT; Gilja OH; McCormack E
J Control Release; 2017 Jan; 245():70-80. PubMed ID: 27871988
[TBL] [Abstract][Full Text] [Related]
17. [The inhibitory effect of paclitaxel nanoparticles on ovarian cancer xenografts and lymphatic targeting].
Lu HX; Xu CJ; Li B; Kang Y; Huang Q; Li LM; Chen QH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):483-6. PubMed ID: 17068619
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated Protein Kinase Kinase 6-fusion Protein (MAP2K6-FP) Potentiates the Anti-tumor effects of Paclitaxel in Ovarian Cancer.
Yuan J; Kang JL; Liao H; Wang XX; Nie ML; Shuai R; Deng C
Anticancer Agents Med Chem; 2015; 15(10):1308-16. PubMed ID: 26118713
[TBL] [Abstract][Full Text] [Related]
19. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
Thaker PH; Yazici S; Nilsson MB; Yokoi K; Tsan RZ; He J; Kim SJ; Fidler IJ; Sood AK
Clin Cancer Res; 2005 Jul; 11(13):4923-33. PubMed ID: 16000591
[TBL] [Abstract][Full Text] [Related]
20. Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells.
Chang S; Guo J; Sun J; Zhu S; Yan Y; Zhu Y; Li M; Wang Z; Xu RX
Ultrason Sonochem; 2013 Jan; 20(1):171-179. PubMed ID: 22841613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
